PropertyValue
?:abstract
  • Coronavirus disease 2019 (COVID-19) originated in Wuhan, China, and caused a pandemic in the world SARS-CoV-2 infections have a great health risk, especially in patients with chronic diseases There are concerns that COVID-19 will be more severe in patients with severe asthma The efficacy and safety of biological agents used in severe asthmatics during SARS-CoV-2 infections are currently unknown In this case report, we present a patient who had been using omalizumab for five years with the diagnosis of severe asthma and died due to COVID-19 To the best of our knowledge, this is the first case of a Turkish patient who died due to COVID-19 under omalizumab treatment for severe asthma
is ?:annotates of
?:creator
?:journal
  • Astim_Allerji_Immunoloji
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Mortality due to COVID-19 in a Patient with Severe Asthma Receiving Omalizumab Treatment: A Case Report
?:type
?:who_covidence_id
  • #965818
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/e2cmpjpn>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/e2cmpjpn>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all